US Military contributions to the global response to pandemic chikungunya.
暂无分享,去创建一个
D. Vaughn | Pamela J. Glass | F. Malinoski | C. Hoke | P. Pittman | P. Gibbs | Tracy Ulderich | Judith G Pace-Templeton | Michelle Mathers | Beverly Fogtman
[1] A. P. Adams,et al. Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope Glycoprotein , 2012, Journal of Virology.
[2] A. Hawksworth,et al. Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012. , 2012, MSMR.
[3] E. Wang,et al. Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism , 2011, PLoS pathogens.
[4] S. Weaver,et al. Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus. , 2011, The American journal of tropical medicine and hygiene.
[5] S. Merler,et al. Transmission Potential of Chikungunya Virus and Control Measures: The Case of Italy , 2011, PloS one.
[6] S. Weaver,et al. Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling. , 2011, Vaccine.
[7] A. Suhrbier,et al. A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. , 2011, Vaccine.
[8] N. Sardesai,et al. A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates , 2011, PLoS neglected tropical diseases.
[9] Mary E. Wilson,et al. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] Mohsin Khan,et al. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. , 2009, Vaccine.
[11] K. Ezzedine,et al. Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations and Associated Factors over a 15-Month Period , 2009, PLoS neglected tropical diseases.
[12] D. Vaughn,et al. Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military. , 2008, Military medicine.
[13] S. Higgs,et al. A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential , 2007, PLoS pathogens.
[14] S. Larrieu,et al. A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. , 2007, The American journal of tropical medicine and hygiene.
[15] Alain Michault,et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] Didier Raoult,et al. Chikungunya outbreaks--the globalization of vectorborne diseases. , 2007, The New England journal of medicine.
[17] E. Farnon. Update: chikungunya fever diagnosed among international travelers--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.
[18] M. Bangs,et al. Tracking the re-emergence of epidemic chikungunya virus in Indonesia. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[19] S. Lemon,et al. Protecting Our Forces , 2002 .
[20] S. Lemon,et al. Recommendations with Accompanying Analysis of Limitations Imposed by Current Department of Defense Structure for Managing Acquisition of Vaccines Against Infectious Diseases , 2002 .
[21] C. Tacket,et al. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. , 2000, The American journal of tropical medicine and hygiene.
[22] M. Diallo,et al. Vectors of Chikungunya virus in Senegal: current data and transmission cycles. , 1999, The American journal of tropical medicine and hygiene.
[23] C. Rossi,et al. Immunologic interference from sequential administration of live attenuated alphavirus vaccines. , 1998, The Journal of infectious diseases.
[24] R. Feigin,et al. Textbook of Pediatric Infectious Diseases (Volume 1) , 1998 .
[25] Turell Mj,et al. Limited potential for mosquito transmission of a live, attenuated chikungunya virus vaccine. , 1992 .
[26] P. Repik,et al. Development of an attenuated strain of chikungunya virus for use in vaccine production. , 1986, Vaccine.
[27] D. Burke,et al. Disappearance of Chikungunya virus from Bangkok. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[28] P. Bartelloni,et al. Production and evaluation of a formalin-killed Chikungunya vaccine. , 1971, Journal of immunology.
[29] F. Hetrick,et al. Chikungunya virus vaccine prepared by Tween-ether extraction. , 1970, Applied microbiology.
[30] L. Binn,et al. Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues. , 1967, The American journal of tropical medicine and hygiene.